Hanyun Ren

Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial

Frits van Rhee, Raymond Wong, Nikhil C. Munshi et al. · The Lancet Oncology · 2014 · 442 citations

Life Sciences, Immunology, Internal Medicine +5

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

Xiaohui Zhang, Jing Chen, Mingzhe Han et al. · Journal of Hematology & Oncology · 2021 · 305 citations · Full text

Medicine, Hematology, Immunology +15

Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial

Jie Jin, Jianxiang Wang, Feifei Chen et al. · The Lancet Oncology · 2013 · 160 citations

Medicine, Hematology, Pharmacology +10

Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial

Hong‐Hu Zhu, Depei Wu, Xin Du et al. · The Lancet Oncology · 2018 · 146 citations

Medicine, Hematology, Oncology +8

Optimal achieved blood pressure in acute intracerebral hemorrhage

Hisatomi Arima, Emma Heeley, Candice Delcourt et al. · Neurology · 2015 · 136 citations · Full text

Medicine, Neurology, Pharmacology +15